Try our Advanced Search for more refined results
Pennsylvania - April, 2011
39 articles
- Pa. Lab Falsified Water Pollution Results, Feds Say
- Cravath, Weil Rep J&J In $21B Deal To Buy Synthes
- Le-Nature's CEO Seeks New Forum For Fraud Trial
- Fulbright Nabs K&L Gates Enviro Team For New Pa. Office
- Convicted Trader's Wife Told To Repay $15M From Scam
- EPA Wants More Info On Chesapeake Fracking Spill
- Arbitrator Named To Oversee Asbestos Coverage Row
- Quecreek Mine Operator PBS Coals Can't Shake Fine
- Latham & Watkins Reps CPG On $150M IPO
- Ranbaxy Can't Dodge Lupin's Suit Over Generic Antara
- Adelphia Execs Finally Win Access To Interview Notes
- Class Cert. Denied In Pitt ADA Suit
- Chesapeake Suspends Fracking In Wake Of Blowout
- Lenders Send Maronda Homes Into Ch. 11
- EBay Wins FTC Approval For $2.4B GSI Buy
- Cypress Sued Over Unapproved Cold Medication
- Crooked Lawyer Dodged Taxes, Too: Grand Jury
- JPML To Weigh Consolidation Of Darvocet Cases
- Pa. DEP Accused Of Rubber-Stamping Gas Permits
- Feds Seek To Revoke Bail For Ponzi Suspect Stinson
- Braun Can't Dodge False Marking Claims On IV Fluids
- Conditional Class Cert. Denied In Wal-Mart OT Action
- Citgo Unit Off The Hook In Oil Tanker Spill
- Allstate Broke Contract, Stole Clients: Ex-Agent
- Bimbo Bakeries Can't Trim Drivers' Class Action
- The Need For A Natural Gas Paradigm Shift
- Advanta GC Rejoins Pepper Hamilton As Partner
- Deformed Consent
- ThyssenKrupp Can't Shake Gas Pipe Warranty Claims
- Cephalon Board Rejects Valeant's $5.7B Merger Bid
- 3rd Circ. Nixes Nurse's ERISA Appeal Over Pay Records
- Ortho Can't Shake False Marking Claims On 5 Drugs
- Mars' Bid To Block Deposition Nixed In Antitrust MDL
- CFTC Accuses Pa. Hedge Fund Of $2.2M Fraud
- FTC Clears Cephalon's $225M Gemin X Buyout
- Urban Outfitters Misread Trends, Shareholders Say
- Lupin Unit Sues Ranbaxy Again Over Generic Antara
- Judge Trims IBM Ponzi Scheme Suit
- Insurer's Bid To Avoid Kids-For-Cash Coverage Revived